{"product_id":"jardianz-dpp-25mg-5mg-con-30-tabletas-empagliflozina-linagliptina","title":"Jardianz Dpp 25Mg\/5Mg With 30 Tablets (Empagliflozin\/Linagliptin)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedications for the treatment of type 2 diabetes.\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eOral antidiabetics.\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eJardianz Dpp.\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eEmpagliflozin\/Linagliptin.\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e30 tablets.\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eBoehringer Ingelheim.\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eJardianz Dpp is indicated for the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise, to improve glycemic control. This medication combines two oral antidiabetic agents: empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Empagliflozin works by reducing glucose reabsorption in the kidneys, increasing its excretion through urine, while linagliptin enhances insulin secretion in response to elevated blood glucose levels and decreases glucose production by the liver.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Jardianz Dpp tablet contains 25 mg of empagliflozin and 5 mg of linagliptin, as well as excipients q.s. for 1 tablet.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eThis medication is contraindicated in patients with known hypersensitivity to any of the formula's components, as well as in those with type 1 diabetes mellitus or diabetic ketoacidosis. It is also contraindicated in patients with severe renal impairment (Glomerular Filtration Rate less than 30 mL\/min).\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution is recommended in patients with a history of pancreatitis, as well as in those with moderate renal impairment. Regular monitoring of renal function and blood glucose levels is important. Use during pregnancy and lactation is not recommended unless strictly necessary and under medical supervision.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Boehringer Ingelheim","offers":[{"title":"Default Title","offer_id":45848322900193,"sku":"7501034692184","price":4321.93,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/planogram__1__d3950bb8-fddd-4de0-88b8-6058e583f999.jpg?v=1744679292","url":"https:\/\/wecarepharma.mx\/en\/products\/jardianz-dpp-25mg-5mg-con-30-tabletas-empagliflozina-linagliptina","provider":"WeCare Pharma","version":"1.0","type":"link"}